This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ceva Sante Animale. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Luc Maroteaux: Innovator in Heart Disease Treatment
Introduction
Luc Maroteaux is a notable inventor based in Paris, France. He has made significant contributions to the field of medicine, particularly in the treatment of valvular heart disease. His innovative approach focuses on utilizing specific compositions to improve heart health in mammals.
Latest Patents
Luc Maroteaux holds a patent for a method aimed at treating valvular heart disease. The patent, titled "Method for the treatment of valvular heart disease comprising administering a composition comprising sarpogrelate," highlights the use of a serotoninergic receptor antagonist, such as sarpogrelate, for preventing heart damage in mammals. This invention represents a crucial advancement in cardiac care.
Career Highlights
Luc Maroteaux is currently associated with Ceva Santé Animale, a company dedicated to animal health. His work there emphasizes the importance of innovative treatments in veterinary medicine. With a focus on improving health outcomes, Maroteaux's contributions are vital to the field.
Collaborations
Luc collaborates with esteemed colleagues, including Laurent Monassier and Jérôme Guyonnet. Their combined expertise fosters a productive environment for innovation and research.
Conclusion
Luc Maroteaux's work in developing treatments for heart disease showcases his commitment to advancing medical science. His patent and collaborations reflect a dedication to improving health outcomes for both humans and animals.